Abstract
Introduction
This study aimed to determine the influence of red light on objective sleep and the relationship between mood and sleep among individuals with insomnia disorder (ID).
Method
57 individuals with insomnia symptoms and 57 healthy participants were randomly divided into three groups (red- and white-light groups, and the black control group), which received different light treatments for 1 h before bedtime. The emotions and subjective alertness of participants were evaluated using Positive and Negative Affect Schedule scales (PANAS) and Karolinska Sleepiness Scale (KSS), their sleeping data were recorded using polysomnography (PSG).
Result
The negative emotion scores were higher in the healthy subject-red light (HS-RL) group than in the HS-white light (WL) and HS-black control (BC) groups (p < 0.001). The anxiety and negative emotion scores were higher in the ID-RL group than in the ID-WL and ID-BC groups (p = 0.007 and p < 0.001, respectively). The KSS scores were lower in the RL group than in the WL and BC groups for both HS and ID group (both p < 0.001). The SOL was shorter in the HS-RL group than in HS-WL group (p = 0.019). Compared with the HS-BC group, the HS-RL group had an increase in microarousal index (MAI) and N1% (p = 0.034 and p = 0.021, respectively), while the total sleep time (TST) and sleep efficiency (SE) decreased (p = 0.001 and p < 0.001, respectively). Compared with the ID-WL group, the SOL was shorter in the ID-RL group (p = 0.043), while TST, SE, number of microarousals (NMA), and numbers of cycles of REM period were increased (p = 0.016, p = 0.046, p = 0.001, and p = 0.041, respectively). Compared with the ID-BC group, the ID-RL group had increases in the SOL, WASO, and the numbers of cycles and NMA in REM period (p = 0.038, p = 0.005, p = 0.045, and p = 0.033, respectively), and a decrease in SE (p = 0.014). The effects of ID-WL (vs. ID-RL group) and ID-BC (vs. ID-RL group) on SOL were mediated by negative emotions (mediating effects were − 37.626 and − 33.768, respectively).
Conclusion
Red light can increase subjective alertness, anxiety, and negative emotions in both healthy subjects and people with ID, which can affect sleep directly or indirectly via the mediating effect of negative emotions.
Keywords: insomnia disorder, red light, positive and negative emotion, alertness, polysomnography
1. Introduction
It is well known that light can affect the circadian rhythms of animals, which in turn regulates their sleep-awake cycle (1). In the natural world, circadian rhythms are often mediated by the change between day and night created by the rotation of the Earth. However, for the past 150 years the natural photoperiod has been disrupted by the presence of artificial light, and global light pollution has grown rapidly (2, 3). Light pollution can be divided into three categories: white- and colored-light pollution, and sky glow. Studies have found that exposure to high-intensity sky glow at night can delay sleep onset to varying degrees, increase the number of nighttime awakenings, reduce total sleep time, and change the proportions of Rapid Eye Movements (REM) and Non-Rapid Eye Movements (NREM) (4). The increase in light pollution interferes with normal sleep, and insomnia is becoming more common, with data indicating that insomnia disorder (ID) prevalence among adults has reached 9.2% in China (3, 5). Controlling lighting at night is therefore of great importance to people.
Red light caught our attention because light regulates the sleep-awake cycle via the intrinsically photosensitive retinal ganglion cells (ipRGCs), and the melanopsin cells expressed in ipRGCs are the least sensitive to red light, which might disrupt the original sleep-awake rhythm of the organism less than white light does (6, 7). Red light is often used as a light source for nighttime illumination in laboratories, and some scholars believe that artificial red light can reduce sleep-awake cycle disruption at night and improve sleep more than ordinary white light (8–10). Some studies have also suggested that ordinary light at night can be replaced with red light to help sleep (9, 11). However, there are also some uncertainties regarding red light, such as it being more likely to induce arousal and negative emotional experiences (12), and to increase arousal levels and alertness (12–14). Increased excitability, high arousal levels, and anxiety are all detrimental factors to sleep onset. Red light was also found to significantly increase daytime alertness in subjects and both subjective and objective alertness in those working night shifts (15, 16), but some studies suggested that red light may inhibit objective alertness (13, 14). Red light may also influence melatonin secretion, which affects sleep (17, 18). Some researchers have also suggested that light pollution at night can indirectly affect human mood by affecting sleep quality, but the complex mechanisms remain unclear (2, 19), and so further exploring the relationships among red light, sleep, and mood is reasonable.
In summary, studies on how light affects circadian rhythms and sleep have expanded to explore the role of monochromatic light, but we are aware of few objective studies with a single-blind randomized design have assessed the impact of red light on sleep structure. We therefore aimed to test the hypothesis that red light affects sleep structure by influencing alertness, mood directly and indirectly, and reveal how red-light impacts sleep by exploring the interrelationship between red light, sleep, and emotion, with the aim of providing a reference for the prevention and alleviation of ID and its complications.
2. Methods
2.1. Participants
This study recruited and enrolled 123 participants aged 18–65 years from Guangzhou city. None of the participants were patients of the researchers. The primary inclusion criterion for participants with insomnia symptoms were self-reported symptoms of insomnia for >3 months based on the diagnostic criteria in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Insomnia was identified in the study participants using validated symptom questionnaires: Insomnia Severity Index (ISI) (20) score ≥ 14, and Pittsburgh Sleep Quality Index (PSQI) (21) score ≥ 8. Healthy participants enrolled in the study did not have insomnia or emotional symptoms. The following exclusion criteria were applied: comorbid cerebral organic diseases and other serious physical diseases, or chronic eye diseases and using photosensitization drugs; comorbid mental disorders or family history of mental disorders (e.g., bipolar disorders, dependence on, or abuse of psychoactive substances); coexistence of other sleep disorders such as sleep-related breathing and movement disorders; using any hypnotics, antidepressants, antipsychotics, or antihistamines during the previous 2 weeks; traveling across time zones or working in shifts during the past week (replacement of night and day shifts); drinking excessive amounts of tea, wine, or coffee; or pregnant and lactating.
After screening, two patients with obstructive sleep apnea syndrome, three with periodic limb movement disorder, and four who dropped out of the study (three patients could not participate in the intervention, and one refused to receive the lighting intervention) were excluded. The procedure was reviewed and approved by the ethics committees of the First Affiliated Hospital of Jinan University and followed the design of the CONSORT extension for randomized trials of nonpharmacological treatment (22). Written informed consent was obtained from all enrolled participants.
2.2. Procedure
The study had a single-blind randomized design. The intervention consisted of receiving three adjustable LED lighting panels (60 cm long and 60 cm wide). Spectral ranges were a white illuminance of 10 ~ 1,400 lx, a wavelength range of 400 ~ 725 nm, and a peak output at 480 nm, and a red illuminance of 10 ~ 250 lx, a wavelength range of 620 ~ 760 nm, and a peak output at 625 nm. According to the standard value of general activity lighting in the bedroom in the Architectural Lighting Design Standards (no. GB 50034–2013) (23), the light intensity in the activity area of a person should be maintained at about 75 lx in a 0.75-m horizontal plane. At baseline, participants completed Mini-International Neuropsychiatric Interview (M.I.N.I.), general condition assessments, and subjective questionnaires to evaluate sleep quality and insomnia severity (ISI and PSQI), and their emotion status [Self-Rating Depression Scale (SDS) (24), and Self-Rating Anxiety Scale (SAS) (25)]. For the intervention, the random envelope method was then used for random grouping. Each lighting group scheme was placed in an opaque envelope with a code written on the outside. After the initial screening of the study subjects on the first night, unique identification numbers were assigned to the participants. Subsequently, the intervention was conducted according to the lighting method specified inside the envelope. Participants were randomly assigned to the red light (RL) group, white light (WL) group, and black control (BC) group, and received light intervention for 1 h before bedtime. Their mood [SAS, SDS, and Positive and Negative Affect Schedule (PANAS) (26)], alertness [Karolinska Sleepiness Scale (KSS) (27)], and objective sleeping structure [polysomnography (PSG)] were assessed (Figure 1).
2.3. Outcome measures
Polysomnography parameters were the primary outcome. All study participants underwent two nights (one screening night and one intervention night) of PSG monitoring in the sleep laboratory. PSG data were collected using Compumedics (Australia), and electrodes were placed according to the 10–20 international electrode placement system. We used electrogram electrodes (F4-M1, F3-M2, C4-M1, C3-M2, O2-M1, and O1-M2), eye movement electrodes (LOC-M1 and ROC-M2), mental muscle electrodes (Chin1 and Chin2), ECG electrodes (ECG1 and ECG2), two anterior tibialis EMG (right and left legs), and pulse oximetry, respiration-related electrodes (nasal–oral thermistor, nasal pressure sensors, and thoracic and abdominal impedance). Electrode attachments for all PSG was performed in the sleep laboratory by trained technicians, and sleep stage scoring was assessed by two experienced PSG technologists who had previously completed concordance programs (agreement for epoch-by-epoch comparisons of sleep stage scoring and event scoring) and were blinded to group allocation. The main indexes were sleep onset latency (SOL), total sleep time (TST), sleep efficiency (SE), number of awakenings (NWAK), wakefulness after sleep onset (WASO), N1, N2, N3, and REM period percentages (N1, N2, N3,and R%), number of microarousals (NMA) and microarousal index (MAI), and indicators relating to the REM period (number of cycles, latency, and microarousal times and index).
The secondary outcomes included PANAS and KSS scores. The PANAS is a 20-item, five-point scale, with 10 factors used to represent positive emotions (interested, focused, enthusiastic, mentally active, alert, energetic, proud, determined, inspired, and energetic) and negative emotions (upset, restless, restless, guilty, hostile, nervous, irritable, shy, fearful, and scared). A higher PANAS score indicates stronger emotional expression. The KSS is a nine-item, nine-point scale that requires subjects to review their psychophysiological state over the past 10 min and select the item that reflects their current state. It is mostly used to subjectively evaluate alertness and fatigue, with lower scores indicating lesser degrees of drowsiness and greater alertness.
2.4. Statistical analysis
Sample size estimates were for paired-samples, two-tailed level of significance at 0.05/3 = 0.0167 and 90% power (28). Assuming a 20% drop-out rate, we aimed to recruit n = 19 in the subgroups to have power to detect statistically significant differences in sleep with red lights. The statistical analysis in this study was performed using SPSS software (version 26.0). Categorical variables were analyzed using chi-square tests. Measurement data that followed a normal distribution were expressed as mean ± standard deviation values. Comparisons between groups were conducted using t-tests for two-group comparisons and one-way ANOVA followed by the Student-Neuman-Keuls (SNK) multiple test for comparisons among multiple groups, assuming homogeneity of variances. In cases where the variances varied, the rank sum test was used for analysis. The original data was then converted into rank variables, and the SNK test was performed for pairwise comparisons. The measurement data that did not conform to a normal distribution were expressed as median and interquartile-range values, with Wilcoxon rank-sum tests used for comparisons between two groups, and the Kruskal-Wallis H test used for comparisons between multiple groups. Partial correlation analysis was used to analyze the correlations between different variables. Mediation effect tests were performed using bootstrapping. All tests were two-sided, and p < 0.05 was considered significant.
3. Results
3.1. General data
The HS group comprised 24 males and 33 females with a median age of 29 years, Body Mass Index (BMI) of 21.40 ± 2.27 kg/m2, and median education duration of 16 years. The ID group comprised 22 males and 35 females with a median age of 36 years, BMI of 21.88 ± 2.62 kg/m2, and median education duration of 15 years. There were no significant differences in gender, age, BMI, or education durations between the HS and ID groups (Table 1) or between the subgroups (Table 1; p > 0.05).
Table 1.
Variables | HS group | ID group | χ2/t/Z/F | p value | |
---|---|---|---|---|---|
Gender (Male/Female) | 24/33 | 22/35 | 0.146 | 0.703 | |
Age | 29 (24, 47) | 36 (28, 50) | −1.862 | 0.063 | |
BMI (kg/m2) | 21.40 ± 2.27 | 21.88 ± 2.62 | −1.029 | 0.306 | |
Education (Year) | 16 (9, 19) | 15 (9, 16) | −1.306 | 0.192 | |
ID-RL group | ID-WL group | ID-BC group | |||
Gender (Male/Female) | 6/13 | 10/9 | 6/13 | 2.369 | 0.306 |
Age | 36 (29, 53) | 30 (27, 48) | 46 (28, 50) | 2.423 | 0.298 |
BMI (kg/m2) | 21.14 ± 2.72 | 22.01 ± 2.74 | 22.48 ± 2.34 | 1.299 | 0.281 |
Education (Year) | 15 (9, 20) | 15 (11, 16) | 9 (9, 20) | 1.434 | 0.488 |
HS-RL group | HS-WL group | HS-BC group | |||
Gender (Male/Female) | 7/12 | 8/11 | 9/10 | 0.423 | 0.806 |
Age | 29 (28, 50) | 30 (27, 47) | 29 (24, 36) | 4.294 | 0.117 |
BMI (kg/m2) | 21.72 ± 2.07 | 21.30 ± 2.01 | 21.19 ± 2.75 | 0.281 | 0.756 |
Education (Year) | 17 (9, 20) | 16 (8, 18) | 16 (15, 18) | 1.834 | 0.400 |
3.2. Data analysis baseline
The Wilcoxon rank-sum test indicated that the PSQI score differed significantly between the ID (average rank = 85.94) and HS (average rank = 29.06) groups (Z = −9.209, p < 0.001; Figure 2A). The Kruskal-Wallis H test indicated that there were no significant differences in PSQI scores between the HS (χ2 = 2.400, p = 0.301) and ID (χ2 = 4.969, p = 0.083) subgroups (Table 2). The ISI score differed significantly between the ID (average rank = 85.96) and HS (average rank = 29.04) groups (Z = −9.218, p < 0.001; Figure 2B). The Kruskal-Wallis H test indicated that the ISI scores did not differ significantly between the HS (χ2 = 1.226, p = 0.542) and ID (χ2 = 1.607, p = 0.448) subgroups (Table 2).
Table 2.
Subgroups | HS group | ID group | ||
---|---|---|---|---|
ISI | PSQI | ISI | PSQI | |
RL group | 2.00 (0.00, 4.00) | 3.00 (2.00, 4.00) | 19.00 (12.00, 22.00) | 14.58 ± 3.44 |
WL group | 1.00 (0.00, 3.00) | 2.00 (1.00, 4.00) | 16.00 (13.00, 19.00) | 12.05 ± 3.97 |
BC group | 2.00 (0.00, 4.00) | 3.00 (2.00, 4.00) | 15.00 (13.00, 19.00) | 12.42 ± 3.53 |
χ2/F | 1.226 | 2.400 | 1.607 | 2.653 |
p value | 0.542 | 0.301 | 0.448 | 0.080 |
Scales | HS group | ID group | Z | p value |
SAS | 30.00 (28.00, 35.00) | 41.00 (34.50, 48.00) | −6.031 | <0.001* |
SDS | 33.00 (29.00, 40.00) | 44.00 (36.00, 51.00) | −5.180 | <0.001* |
*indicates statistically significant difference (p < 0.05).
There were significant differences in SAS and SDS scores between the HS and ID groups (Z = −6.031, p < 0.001 and Z = −5.180, p < 0.001, respectively; Table 2). There were no significant differences among the SAS and SDS scores of the subgroups (p > 0.05).
3.3. Data analysis of lighting intervention
3.3.1. Emotion and alertness assessment
There were no significant differences in SAS and SDS scores among the HS subgroups (χ2 = 5.163, p = 0.076 and F = 2.853, p = 0.066, respectively). However, significant differences were observed in SAS scores among the ID subgroups (F = 5.426, p = 0.007). After conducting SNK test multiple comparisons, it was found that the mean SAS score of the ID-RL group (46.63 ± 7.06) was higher than that of the ID-WL group (38.74 ± 7.47) and ID-BC group (41.42 ± 7.98), and this difference was statistically significant. However, there was no statistical difference between the ID-WL group and ID-BC group (p = 0.276). No significant differences were found in the mean SDS scores among the ID subgroups (F = 3.067, p = 0.055; Table 3). One-way ANOVAs revealed significant differences in SAS scores between the post-intervention and baseline measurements in the ID-RL (average rank = 26.63) and HS-RL (average rank = 12.37) groups (Z = −4.005, p < 0.001; Table 3).
Table 3.
HS group | ID group | |||||
---|---|---|---|---|---|---|
SAS | SDS | KSS | SAS | SDS | KSS | |
RL group | 33.00 (27.00, 37.00) | 35.74 ± 6.85 | 2.00 (2.00, 4.00) | 46.63 ± 7.06 | 48.42 ± 9.06 | 4.00 (3.00, 5.00) |
WL group | 28.00 (26.00, 33.00) | 31.79 ± 5.00 | 5.00 (3.00, 6.00) | 38.74 ± 7.47 | 41.95 ± 8.24 | 6.00 (4.00, 7.00) |
BC group | 27.00 (30.00, 35.00) | 36.00 ± 6.26 | 7.00 (5.00, 8.00) | 41.42 ± 7.98 | 42.74 ± 9.05 | 8.00 (6.00, 9.00) |
χ2/F | 5.163 | 2.853 | 24.780 | 5.426 | 3.067 | 24.766 |
p value | 0.076 | 0.066 | <0.001* | 0.007* | 0.055 | <0.001* |
*indicates statistically significant difference (p < 0.05).
The HS group (average rank = 2847.00) had significantly lower KSS scores compared to the ID group (average rank = 3708.00; Z = −2.459, p = 0.014). Significant differences were also observed in the KSS scores among the HS (χ2 = 24.780, p < 0.001) and ID (χ2 = 24.766, p < 0.001) subgroups (Table 3).
The positive emotion score of the PANAS did not differ significantly between the HS and ID groups (t = 0.164, p = 0.870), while the negative emotion score was higher in the ID group than in the HS group (Z = −2.135, p = 0.033). There were significant differences in positive (F = 10.816, p < 0.001) and negative (F = 27.087, p < 0.001) emotions among the three HS subgroups. After conducting SNK tests for multiple comparisons, it was found that the positive emotion scores of the HS-RL group (30.32 ± 2.95) and HS-WL group (28.21 ± 3.43) were higher than those of the HS-BC group (25.21 ± 3.78; p < 0.05). However, there was no significant difference between the HS-RL group and HS-WL group (p = 0.062). Similarly, statistical differences were observed in negative emotions among the three HS groups (F = 27.087, p = 0.000). After conducting SNK tests for multiple comparisons, it was found that the negative emotion scores significantly differed among the HS-RL (25.42 ± 3.04, highest), HS-WL (19.89 ± 2.13), and HS-BC (19.63 ± 2.95) groups. However, there was no significant difference between the HS-WL group and the HS-BC group (p = 0.768).
Significant differences were also observed in positive (F = 5.534, p = 0.007) and negative (F = 55.597, p < 0.001) emotions among the ID subgroups. After conducting SNK tests for multiple comparisons, it was found that the positive emotion scores significantly differed between the ID-RL (29.89 ± 3.46) and ID-BC (25.84 ± 4.14) groups (p < 0.05). However, there was no significant difference between the ID-RL group and the ID-WL group (27.63 ± 3.66, p = 0.069), or between the ID-WL group and ID-BC group (p = 0.149). Regarding negative emotions, the scores in the ID-RL group (30.26 ± 3.66) were higher than those in the ID-WL group (20.53 ± 2.74) and ID-BC group (21.05 ± 3.14). However, the difference between the ID-WL group and ID-BC group was not statistically significant (p = 0.614).
The differences in scores for each item in the PANAS scale were specifically analyzed. In the HS group, two items in the HS-BC group (Excited and Attentive) scored lower than the other two groups (p < 0.05). The order of scores for the Alert item was HS-RL group > HS-WL group > HS-BC group (Figure 3A). For negative emotions, three items in the HS-RL group (Upset, Distressed, and Nervous) scored higher than the other two groups (p < 0.05). None of the other items showed statistical significance (p > 0.05; Figure 3B). In the ID group, two items in the ID-BC group (Excited and Attentive) scored lower than the other two groups (p < 0.05) for positive emotion items. The order of scores for high alertness items was ID-RL group > ID-WL group > ID-BC group (Figure 4A). For negative emotion items, the items Upset, Scared, Distressed, Irritable, Nervous, and Jittery in the ID-RL group scored higher than the other two groups (p < 0.05; Figure 4B). There was no statistically significant difference for the other items (p > 0.05).
3.3.2. PSG data
Compared to the HS-BC group, the HS-WL group demonstrated longer SOL (χ2 = 9.780, p = 0.008), WASO (χ2 = 16.580, p < 0.001), and higher NWAK (F = 3.399, p = 0.041). The HS-BC group had significantly higher TST (F = 8.115, p = 0.001) and SE (χ2 = 23.108, p < 0.001) than both the HS-RL and HS-WL groups. The MAI was higher in the HS-RL and HS-WL groups than in the HS-BC group (F = 3.872, p = 0.027). Additionally, the NS-BC group had a lower N1% compared to the NS-WL and NS-RL groups (χ2 = 11.129, p = 0.004). There was no significant difference among HS subgroups in other parameters statistically (p > 0.05; Table 4).
Table 4.
HS-RL group | HS-WL group | HS-BC group | F/χ2 | p value | |
---|---|---|---|---|---|
SOL (min) | 4.50 (2.00, 7.00) | 9.50 (5.50, 15.50) | 4.50 (2.50, 6.50) | 9.780 | 0.008* |
TST (min) | 386.34 ± 37.40 | 395.74 ± 57.24 | 446.24 ± 51.12 | 8.115 | 0.001* |
SE (%) | 88.50 (85.50, 91.50) | 84.80 (80.60, 87.80) | 93.70 (92.00, 95.20) | 23.108 | <0.001* |
WASO (min) | 50.00 (27.00, 64.00) | 61.5 (45.50, 73.00) | 24.00 (17.00, 36.50) | 16.580 | <0.001* |
NWAK (times) | 27.26 ± 9.96 | 29.00 ± 11.02 | 21.58 ± 5.68 | 3.399 | 0.041* |
NMA (times) | 53.05 ± 17.68 | 54.00 ± 25.93 | 44.32 ± 13.85 | 1.381 | 0.260 |
MAI | 8.23 ± 2.42 | 8.19 ± 3.89 | 5.98 ± 1.84 | 3.872 | 0.027* |
N1% | 11.30 (8.30, 13.90) | 12.60 (8.60, 16.10) | 6.60 (5.20, 8.60) | 11.129 | 0.004* |
N2% | 45.40 ± 6.25 | 45.65 ± 7.11 | 45.22 ± 5.28 | 0.022 | 0.978 |
N3% | 21.79 ± 7.59 | 21.31 ± 7.27 | 24.32 ± 6.78 | 0.954 | 0.392 |
R% | 21.46 ± 5.94 | 20.63 ± 5.504 | 22.76 ± 4.51 | 0.766 | 0.470 |
Rem period number of cycles (number) | 5.00 (3.00, 5.00) | 4.00 (3.00, 5.00) | 4.00 (4.00, 6.00) | 1.038 | 0.595 |
Rem period SOL (min) | 84.00 (69.50, 121.00) | 95.00 (65.00, 152.00) | 80.50 (64.00, 106.50) | 1.158 | 0.560 |
Rem period NMA (times) | 8.00 (5.00, 13.00) | 12.00 (2.00, 16.00) | 7.00 (4.00, 17.00) | 0.112 | 0.946 |
Rem period MAI (times) | 5.60 (3.90, 8.70) | 5.90 (1.50, 10.30) | 4.20 (2.80, 7.10) | 0.667 | 0.717 |
ID-RL group | ID-WL group | ID-BC group | F/χ 2 | p value | |
SOL (min) | 12.50 (10.50, 19.50) | 25.50 (18.00, 42.50) | 7.50 (3.00, 10.00) | 24.437 | <0.001* |
TST (min) | 401.03 ± 58.83 | 341.21 ± 71.49 | 395.32 ± 71.50 | 4.539 | 0.015* |
SE (%) | 79.35 ± 9.83 | 72.19 ± 12.17 | 88.49 ± 5.43 | 13.879 | <0.001* |
WASO (min) | 89.18 ± 52.30 | 99.79 ± 51.54 | 43.68 ± 23.57 | 8.516 | 0.001* |
NWAK (times) | 32.95 ± 11.76 | 26.95 ± 10.89 | 26.47 ± 12.55 | 1.792 | 0.176 |
NMA (times) | 53.21 ± 19.34 | 58.42 ± 24.58 | 43.68 ± 19.92 | 2.316 | 0.108 |
MAI | 8.29 ± 3.67 | 10.56 ± 4.39 | 6.57 ± 2.70 | 5.709 | 0.006* |
N1% | 13.30 (7.50, 17.20) | 11.60 (7.90, 17.70) | 8.40 (6.10, 14.10) | 2.906 | 0.234 |
N2% | 51.21 ± 11.55 | 48.95 ± 9.68 | 47.88 ± 7.46 | 0.583 | 0.562 |
N3% | 17.35 ± 7.48 | 21.89 ± 8.89 | 20.05 ± 6.85 | 1.639 | 0.204 |
R% | 18.92 ± 5.98 | 16.42 ± 7.14 | 21.95 ± 5.15 | 3.861 | 0.027* |
Rem period number of cycles (number) | 5.00 (4.00, 7.00) | 3.00 (3.00, 4.00) | 4.00 (4.00, 5.00) | 13.548 | 0.001* |
Rem period SOL (min) | 92.50 (71.50, 153.00) | 99.00 (77.00, 153.50) | 68.5 (61.50, 135.00) | 2.291 | 0.318 |
Rem period NMA (times) | 15.00 (8.00, 19.00) | 8.00 (2.00, 11.00) | 9.00 (3.00, 13.00) | 7.157 | 0.028* |
Rem period MAI (times) | 8.14 ± 3.773 | 7.28 ± 4.174 | 5.91 ± 3.818 | 1.556 | 0.220 |
*indicates statistically significant difference (p < 0.05).
Insomnia disorder groups showed significant differences in SOL (χ2 = 24.196, p < 0.001), with the ID-WL group having the longest duration, followed by the ID-RL group, and ID-BC group. SE (F = 13.879, p < 0.001) showed the opposite pattern, with the ID-BC group having a higher sleep efficiency than the ID-RL group, which in turn was higher than the ID-WL group. Compared to the other two groups, the ID-BC group had a longer TST (F = 4.539, p = 0.015) and shorter WASO (F = 8.516, p = 0.001). Compared to the ID-WL group, the ID-BC group has a smaller MAI (F = 5.709, p = 0.006) and a higher R% (F = 3.861, p = 0.027). Additionally, number of cycles (χ2 = 13.548, p = 0.001) and NMA during the REM period (χ2 = 7.157, p = 0.028) were higher in the ID-RL group than that in the ID-WL and ID-BC groups (Table 4).
3.4. Correlation analysis of emotion, alertness, and PSG parameters
The correlations between scores of emotion scales, alertness scales, and sleeping parameters were considered partial based on the impact of demographic variables (age, gender, BMI, and education duration). The results indicated that SOL and NWAK were positively correlated with SAS, SDS, and negative emotion scores; SE was negatively correlated with SAS and SDS scores, REM period NMA and MAI were positively correlated with SAS and negative emotion scores, while KSS scores and sleeping parameters were not significantly correlated (Table 5).
Table 5.
SAS | SDS | KSS | Positive emotions | Negative emotions | |
---|---|---|---|---|---|
SOL (min) | 0.440 * | 0.331* | 0.113 | 0.062 | 0.351* |
TST (min) | −0.004 | 0.030 | 0.148 | −0.096 | 0.068 |
SE (%) | −0.244* | −0.200* | 0.069 | −0.080 | −0.169 |
WASO (min) | 0.180 | 0.164 | −0.095 | 0.057 | 0.127 |
NWAK (times) | 0.227* | 0.241* | −0.094 | 0.098 | 0.221* |
NMA (times) | 0.104 | 0.112 | −0.129 | −0.106 | 0.084 |
MAI | 0.107 | 0.107 | −0.143 | −0.055 | 0.066 |
N1% | 0.057 | 0.076 | −0.141 | 0.048 | 0.040 |
N2% | 0.111 | 0.094 | −0.022 | 0.073 | 0.071 |
N3% | −0.066 | −0.083 | 0.058 | −0.019 | −0.116 |
R% | −0.108 | −0.074 | 0.086 | −0.128 | 0.024 |
Rem period number of cycles (number) | 0.010 | 0.082 | 0.081 | 0.014 | 0.143 |
Rem period SOL (min) | 0.123 | 0.139 | −0.150 | −0.039 | 0.028 |
Rem period NMA (times) | 0.216* | 0.143 | 0.044 | −0.034 | 0.298* |
Rem period MAI (times) | 0.247* | 0.113 | −0.003 | 0.020 | 0.250* |
*indicates statistically significant difference (p < 0.05).
3.5. Analysis of the mediating effect of emotion
We examined the potential mediating effect of negative emotion. The mediation effect analysis procedure (29) involved two dummy variables with red light as the reference (independent variable), and SOL (dependent variable), negative emotion (mediator variable), and demographic variables (control variable). The bootstrapping method was used to test the mediation effect (30). The results indicated that the mediation model was a significant predictor (p < 0.05; Table 6), which suggests that negative emotions play a partial mediating role (Table 6).
Table 6.
R | R2 | Adjusted R2 | F | p | ||
---|---|---|---|---|---|---|
Model 1 | 0.845 | 0.715 | 0 0.680 | 20.867 | <0.001 | |
Model 2 | 0.851 | 0.724 | 0 0.684 | 18.313 | <0.001 | |
ID group | Effect | SE (boot) | T | p | 95% CI | |
LLCI | ULCI | |||||
WL group vs. RL group | −37.626 | 9.697 | −8.976 | <0.001 | −59.768 | −21.879 |
BC group vs. RL group | −33.768 | 9.404 | −8.027 | <0.001 | −54.146 | −18.985 |
Model 1: variables to mediating variables; Model 2: variables to mediating variables to dependent variables.
4. Discussion
We report here that even being exposed to 75-lx red light for 1 h before bedtime has an impact on sleeping. The effects of red light are not limited to sleep, but also affect mood and alertness. Specifically, PSG parameters and scores on the KSS and PANAS were lower among participants with insomnia symptoms, indicating influences in sleeping, mood, and alertness.
We observed that subjective sleep quality was worse and the degree of dissatisfaction with sleep patterns and daytime functional impairment were greater in individuals with insomnia disorder than in healthy people (31, 32). At the same time, individuals with insomnia experienced anxiety and depression more often than the healthy population, which is consistent with previous research (33, 34). Insomnia, anxiety, and depression often coexist and interact with each other. There is evidence that sleep deprivation leads to reduced availability of dopamine D2/D3 receptors in the striatum and serotonin transporter gene expression dysregulation (35, 36). However, dopamine and serotonin play important roles in the mechanisms of depression and anxiety. Decreased dopamine content is closely related to anhedonia in depression (37). Short serotonin allele mutations lead to reduced serotonin uptake and increased susceptibility to anxiety and depression (38). Anxiety and negative mood also occur significantly more often after a red-light intervention in people with insomnia, and they tend to be emotionally unstable. Xie et al. (39) found that red-light exposure increased anxiety-like behaviors in mice. Previous research on color and emotion has also linked red light with negative events, with even children aged 5–10 years being prone to negative feelings under red-light backgrounds (40, 41), also people with strong anxiety traits commonly had greater anxiety levels when faced with different color stimuli (42). El-Sheikh et al. (43) studied the relationship between emotion regulation and sleep problems and found that decreased vagal inhibition levels were indicators of worse emotion regulation. Chronic insomnia can affect cognition, and dysfunctional cognition internalizes negative emotions. People with poor sleep quality may have worse emotional stability (44) and are more likely than healthy individuals to have fluctuating anxiety levels and other negative emotions after receiving a red-light intervention.
We found that individuals with insomnia symptoms had higher levels of hypersomnia and decreased alertness, since insufficient sleep reduces alertness. Even though the intervention period was short, with only one night of light treatment, the data are insightful. Yang et al. (45) found that participants experienced a significant decrease in alertness after a night of sleep deprivation. Another study found that long-term shifts resulted in a decrease in average sleep time, which affected alertness on the following day (46). Chronic sleep deprivation (sleeping for less than 5.6 h per day) also impairs attention and reduces self-assessment of alertness (47), but people with relatively stable sleep durations maintain more consistent levels of work performance and alertness during the night (48). A red-light intervention can increase subjective alertness and improve drowsiness for participants with insomnia. Figueiro et al. (16) found that red light can improve the subjective and objective alertness of night shift workers without affecting melatonin secretion and sleep. Askaripoor et al. (13) found that red light can improve physiological alertness more than white light can. In summary, red light has been found to have specific advantages in alertness, improving it without affecting melatonin secretion; it may also improve the performance of night workers.
The present study is the first that we are aware of that employed red light as a factor to investigate objective sleeping and the relationship between sleeping parameters, emotion, and vigilance. Red light even affected sleep at 75 lx, which was consistent with previous findings (28). Tähkämö et al. (49) also suggested that even the longest red-light wavelength (631 nm) may induce resetting of circadian rhythms. Red light has specific advantages in sleep initiation when compared with white light. This may due to red light resetting the melatonin rhythm via visual photoreceptors (50), but there was no evidence indicating that red light increases melatonin secretion, which may be related to the finding that red light improves sleep initiation rather than sleep maintenance.
We also found changes in the REM period, such as increased number of cycles and NMA during REM period for people with insomnia after a red-light intervention, which was positively correlated with anxiety and negative emotion. A previous study found that experiencing negative emotion events before bedtime can fragment sleep, with especially the percentage of REM sleep decreasing and the number of awakenings during REM sleep increasing (51). Other previous studies found that rats subjected to REM sleep deprivation exhibited depressive symptoms, decreased pleasure-seeking behaviors, and increased alcohol preference (52, 53). The activity of some brain structures (e.g., the amygdala, cingulate gyrus, and dorsolateral prefrontal cortex) increase during REM sleep, and these areas also play crucial roles in emotion regulation and memory processing (53, 54). Changes in REM sleep may therefore be induced by red light before bedtime, which causes negative emotions in people with insomnia. We found that higher levels of anxiety, depression, and negative emotion before bedtime were associated with a longer SOL, lower SE, and more WASO during the night, and larger NMA during REM sleep; these observations were consistent with previous studies.
Negative mood can lead to decreased sleep quality, and poor sleep quality can increase the probability of negative mood (55–57). Orchard et al. (58) found that depression and anxiety disorders were accompanied by insufficient sleep and poor sleep quality in adolescents, and sleep parameters could predict the degree of depression and anxiety and whether the subject will subsequently suffer from anxiety or depressive disorders. In contrast, unlike previous predictions, the increase of subjective alertness caused by red light was not sufficient to affect sleep, and so the correct conclusion was that subjective alertness is time-sensitive, which needs further evidence from follow-up studies.
A black environment before bedtime was helpful in improving sleep quality (short SOL, increased TST and SE, and better sleep continuity) in both individuals with insomnia and healthy participants, especially for the R%. A previous study also found decreases in the REM period and the proportion in individuals with insomnia symptoms (59), and REM sleep is closely related to cognition, emotion, and many physical diseases. Changes in REM sleep can cause a decline in cognitive function and manifest as emotional regulation disorders (60, 61). Our study therefore suggests that people with ID should be exposed to appropriate light stimulation before bedtime, because reducing the amount of light can help restore the proportion of REM sleep.
In summary, we have explored the effects of red light on objective sleep structure, mood, and alertness in people with insomnia disorders. Red light can directly influence sleep, such as the fragmented changes in REM period, and negative emotion plays an important role in this process. Increased subjective alertness, anxiety, and negative mood may be responsible for changes in REM sleep under red light. These findings provide solid evidence for the selection of a control light level in biological experiments and reasonable lighting before bedtime, we will continue to test the biological role of red light in the follow-up trials.
Data availability statement
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.
Ethics statement
The studies involving humans were approved by Ethics Committees in the First Affiliated Hospital of Jinan University. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.
Author contributions
RP and GZ were involved in the design and research methodologies and drafted the manuscript. FD and WL were involved in data curation and investigation. JP revised the manuscript. All authors contributed to the article and approved the submitted version.
Funding
This work was also supported by a grant from National Key Research and Development Program of China (grant number: 2022YFC2503902).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Acknowledgments
The authors thank JP and Guangdong Cosio Lighting Co., Ltd. for their support with technical issues and adjustable LED lighting panels.
Glossary
ID | Insomnia disorder |
HS | Healthy subject |
RL | Red light |
WL | Write light |
BC | Black control |
ipRGCs | Intrinsically photoreceptor retinal ganglion cells |
REM | Rapid eye movements |
NREM | Non-rapid eye movements |
PSG | Polysomnography |
EEG | Electroencephalogram |
EOG | Electrooculogram |
EMG | Electromyogram |
ISI | Insomnia severity index |
PSQI | Pittsburgh sleep quality index |
SDS | Self-rating depression scale |
SAS | Self-rating anxiety scale |
PANAS | Positive and negative affect scale |
KSS | Karolinska sleepiness scale |
AASM | American academy of sleep medicine |
SOL | Sleep onset latency |
TST | Total sleep time |
SE | Sleep efficiency |
NWAK | Number of awakenings |
WASO | Wakefulness after sleep onset |
NMA | Number of microarousal |
MAI | Microarousal index |
BMI | Body mass index |
HS-RL | Healthy subject red light |
HS-WL | Healthy subject write light |
HS-BC | Healthy subject black control |
ID-RL | Insomnia disorder red light |
ID-WL | Insomnia disorder write light |
ID-BC | Insomnia disorder black control |
References
- 1.Schmoll C, Tendo C, Aspinall P, Dhillon B. Reaction time as a measure of enhanced blue-light mediated cognitive function following cataract surgery. Br J Ophthalmol. (2011) 95:1656–9. doi: 10.1136/bjophthalmol-2011-300677 [DOI] [PubMed] [Google Scholar]
- 2.Davies TW, Smyth T. Why artificial light at night should be a focus for global change research in the 21st century. Glob Chang Biol. (2018) 24:872–82. doi: 10.1111/gcb.13927 [DOI] [PubMed] [Google Scholar]
- 3.Gaston KJ, Davies TW, Nedelec SL, Holt LA. Impacts of artificial light at night on biological timings. Annu Rev Ecol Evol Syst. (2017) 48:49–68. doi: 10.1146/annurev-ecolsys-110316-022745 [DOI] [Google Scholar]
- 4.Aulsebrook AE, Jones TM, Mulder RA, Lesku JA. Impacts of artificial light at night on sleep: a review and prospectus. Journal of experimental zoology part a: ecological and integrative. Physiology. (2018) 329:409–18. doi: 10.1002/jez.2244 [DOI] [PubMed] [Google Scholar]
- 5.Yu-Tao X, Xin M, Zhuo-Ji C, Shu-Ran L, Ying-Qiang X, Hong-Li G, et al. The prevalence of insomnia, its sociodemographic and clinical correlates, and treatment in rural and urban regions of Beijing, China: a general population-based survey. Sleep. (2008) 31:1655–62. doi: 10.1093/sleep/31.12.1655 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lockley SW, Brainard GC, Czeisler CA. High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. J Clin Endocrinol Metab. (2003) 8:4502–5. [DOI] [PubMed] [Google Scholar]
- 7.Newman LA, Walker MT, Brown RL, Cronin TW, Robinson PR. Melanopsin forms a functional short-wavelength Photopigment. Biochemistry. (2003) 42:12734–8. doi: 10.1021/bi035418z, PMID: [DOI] [PubMed] [Google Scholar]
- 8.Figueiro MG, Sahin L, Roohan C, Kalsher M, Plitnick B, Rea MS. Effects of red light on sleep inertia. Nature and science of. Sleep. (2019) 11:45–57. doi: 10.2147/NSS.S195563, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Martin D, Hurlbert A, Cousins DA. Sleep disturbance and the change from white to red lighting at night on old age psychiatry wards: a quality improvement project. Arch Psychiatr Nurs. (2018) 32:379–83. doi: 10.1016/j.apnu.2017.12.001 [DOI] [PubMed] [Google Scholar]
- 10.van der Meijden WP, te Lindert BHW, Ramautar JR, Wei Y, Coppens JE, Kamermans M, et al. Sustained effects of prior red light on pupil diameter and vigilance during subsequent darkness. Proc R Soc B Biol Sci. (1883) 285:20180989. doi: 10.1098/rspb.2018.0989, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Nédélec M, Halson S, Delecroix B, Abaidia AE, Ahmaidi S, Dupont G. Sleep hygiene and recovery strategies in elite soccer players. Sports Med. (2015) 45:1547–59. doi: 10.1007/s40279-015-0377-9, PMID: [DOI] [PubMed] [Google Scholar]
- 12.Valdez P, Mehrabian A. Effects of color on emotions. J Exp Psychol Gen. (1994) 123:394–409. doi: 10.1037/0096-3445.123.4.394 [DOI] [PubMed] [Google Scholar]
- 13.Askaripoor T, Motamedzade M, Golmohammadi R, Farhadian M, Babamiri M, Samavati M. Effects of light intervention on alertness and mental performance during the post-lunch dip: a multi-measure study. Ind Health. (2019) 57:511–24. doi: 10.2486/indhealth.2018-0030, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Łaszewska K, Goroncy A, Weber P, Pracki T, Tafil-Klawe M. Influence of the spectral quality of light on daytime alertness levels in humans. Adv Cogn Psychol. (2018) 14:192–208. doi: 10.5709/acp-0250-0, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Sahin L, Wood BM, Plitnick B, Figueiro MG. Daytime light exposure: effects on biomarkers, measures of alertness, and performance. Behav Brain Res. (2014) 274:176–85. doi: 10.1016/j.bbr.2014.08.017, PMID: [DOI] [PubMed] [Google Scholar]
- 16.Figueiro MG, Pedler D. Red light: a novel, non-pharmacological intervention to promote alertness in shift workers. J Saf Res. (2020) 74:169–77. doi: 10.1016/j.jsr.2020.06.003, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Claustrat B, Leston J. Melatonin: physiological effects in humans. Neurochirurgie. (2015) 61:77–84. doi: 10.1016/j.neuchi.2015.03.002 [DOI] [PubMed] [Google Scholar]
- 18.Zhao J, Tian Y, Nie J, Xu J, Liu D. Red light and the sleep quality and endurance performance of Chinese female basketball players. J Athl Train. (2012) 47:673–8. doi: 10.4085/1062-6050-47.6.08, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Bedrosian N. Influence of the modern light environment on mood. Mol Psychiatry. (2013) 18:751–7. doi: 10.1038/mp.2013.70 [DOI] [PubMed] [Google Scholar]
- 20.Gullickson T, Ramser P. Insomnia: psychological assessment and management. PsycCRITIQUES. (1996) 41:195–97. doi: 10.1037/003013 [DOI] [Google Scholar]
- 21.Tsai PS, Wang SY, Wang MY, Su CT, Yang TT, Huang CJ, et al. Psychometric evaluation of the Chinese version of the Pittsburgh sleep quality index (CPSQI) in primary insomnia and control subjects. Qual Life Res. (2005) 14:1943–52. doi: 10.1007/s11136-005-4346-x, PMID: [DOI] [PubMed] [Google Scholar]
- 22.Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. (2009) 148:295–309. doi: 10.7326/0003-4819-148-4-200802190-00008 [DOI] [PubMed] [Google Scholar]
- 23.National Standard of the People's Republic of China . Housing and Urban-rural Development of The People's Republic of China GAoQS, Inspection and Quarantine o of the People's Republic of China. GB 50034-2013 Standard for Lighting Design of Buildings. Beijing, China: China architecture and building press; (2014). [Google Scholar]
- 24.Chunfang Wang ZC, Qing X. Analysis of the depression self-rating scale—SDS in 1,340 normal subjects. Chin J Nervous Mental Diseases. (1986) 5:267–68. [Google Scholar]
- 25.William WKZMD. A rating instrument for anxiety disorders. Psychosomatics. (1971) 12:371–9. doi: 10.1016/S0033-3182(71)71479-0 [DOI] [PubMed] [Google Scholar]
- 26.Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. (1988) 54:1063–70. doi: 10.1037/0022-3514.54.6.1063 [DOI] [PubMed] [Google Scholar]
- 27.Akerstedt T, Gillberg M. Subjective and objective sleepiness in the active individual. Int J Neurosci. (1990) 52:29–37. doi: 10.3109/00207459008994241 [DOI] [PubMed] [Google Scholar]
- 28.Zhang Z, Wang HJ, Wang DR, Qu WM, Huang ZL. Red light at intensities above 10lx alters sleep–wake behavior in mice. Light Sci Appl. (2018) 6:e16231. doi: 10.1038/lsa.2016.231 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Zhao X, Lynch JG, Chen Q. Reconsidering baron and Kenny: Myths and truths about mediation analysis. J Consum Res. (2010) 37:197–206. doi: 10.1086/651257 [DOI] [Google Scholar]
- 30.Hayes AF, Preacher KJ. Multicategorical X in mediation analysis indirect and direct effects of a multicategorical causal agent in statistical mediation analysis. (2011).
- 31.Morin CM, Jarrin DC. Epidemiology of insomnia: prevalence, course, risk factors, and public health burden. Sleep Med Clin. (2022) 17:173–91. doi: 10.1016/j.jsmc.2022.03.003 [DOI] [PubMed] [Google Scholar]
- 32.Bastien CH, Ceklic T, St-Hilaire P, Desmarais F, Lefrançois J, Pedneault-Drolet M. Insomnia and sleep misperception. Pathol Biol. (2014) 62:241–51. doi: 10.1016/j.patbio.2014.07.003 [DOI] [PubMed] [Google Scholar]
- 33.Riemann D, Benz F, Dressle RJ, Espie CA, Johann AF, Blanken TF, et al. Insomnia disorder: state of the science and challenges for the future. J Sleep Res. (2022) 31:e13604. doi: 10.1111/jsr.13604, PMID: [DOI] [PubMed] [Google Scholar]
- 34.Chen P-J, Huang CL-C, Weng S-F, Wu M-P, Ho C-H, Wang J-J, et al. Relapse insomnia increases greater risk of anxiety and depression: evidence from a population-based 4-year cohort study. Sleep Med. (2017) 38:122–9. doi: 10.1016/j.sleep.2017.07.016, PMID: [DOI] [PubMed] [Google Scholar]
- 35.Deuschle M, Schredl M, Schilling C, Wüst S, Frank J, Witt SH, et al. Association between a serotonin transporter length polymorphism and primary insomnia. Sleep. (2010) 33:343–7. doi: 10.1093/sleep/33.3.343, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Volkow ND, Tomasi D, Wang G-J, Telang F, Fowler JS, Logan J, et al. Evidence that sleep deprivation downregulates dopamine D2R in ventral striatum in the human brain. J Neurosci. (2012) 32:6711–7. doi: 10.1523/JNEUROSCI.0045-12.2012, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Auerbach RP, Admon R, Pizzagalli DA. Adolescent depression: stress and reward dysfunction. Harv Rev Psychiatry. (2014) 22:139–48. doi: 10.1097/HRP.0000000000000034, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Sharpley CF, Palanisamy SKA, Glyde NS, Dillingham PW, Agnew LL. An update on the interaction between the serotonin transporter promoter variant (5-HTTLPR), stress and depression, plus an exploration of non-confirming findings. Behav Brain Res. (2014) 273:89–105. doi: 10.1016/j.bbr.2014.07.030 [DOI] [PubMed] [Google Scholar]
- 39.Xie B, Zhang Y, Qi H, Yao H, Shang Y, Yuan S, et al. Red light exaggerated sepsis-induced learning impairments and anxiety-like behaviors. Aging (Albany NY). (2020) 12:23739–60. doi: 10.18632/aging.103940, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Gil S, Le Bigot L. Colour and emotion: children also associate red with negative valence. Dev Sci. (2016) 19:1087–94. doi: 10.1111/desc.12382, PMID: [DOI] [PubMed] [Google Scholar]
- 41.Sutton TM, Altarriba J. Color associations to emotion and emotion-laden words: a collection of norms for stimulus construction and selection. Behav Res Methods. (2016) 48:686–728. doi: 10.3758/s13428-015-0598-8 [DOI] [PubMed] [Google Scholar]
- 42.Reeves RA, Edmonds EM, Transou DL. Effects of color and trait anxiety on state anxiety. Percept Mot Skills. (1978) 46:855–8. doi: 10.2466/pms.1978.46.3.855 [DOI] [PubMed] [Google Scholar]
- 43.El-Sheikh M, Buckhalt JA. Vagal regulation and emotional intensity predict children's sleep problems. Dev Psychobiol. (2005) 46:307–17. doi: 10.1002/dev.20066, PMID: [DOI] [PubMed] [Google Scholar]
- 44.Medrano-Martínez P, Ramos-Platón MJ. Cognitive and emotional alterations in chronic insomnia. Rev Neurol. (2016) 62:170–8. doi: 10.1016/j.smrv.2017.06.009 PMID: [DOI] [PubMed] [Google Scholar]
- 45.Yang FN, Xu S, Chai Y, Basner M, Dinges DF, Rao H. Sleep deprivation enhances inter-stimulus interval effect on vigilant attention performance. Sleep. (2018) 41:zsy189. doi: 10.1093/sleep/zsy189, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Basner M, Dinges DF, Shea JA, Small DS, Zhu J, Norton L, et al. Sleep and alertness in medical interns and residents: an observational study on the role of extended shifts. Sleep. (2017) 40:zsx027. doi: 10.1093/sleep/zsx027 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.McHill AW, Hull JT, Wang W, Czeisler CA, Klerman EB. Chronic sleep curtailment, even without extended (>16-h) wakefulness, degrades human vigilance performance. Proc Natl Acad Sci U S A. (2018) 115:6070–5. doi: 10.1073/pnas.1706694115, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Isherwood CM, Chinoy ED, Murphy AS, Kim JH, Wang W, Duffy JF. Scheduled afternoon-evening sleep leads to better night shift performance in older adults. Occup Environ Med. (2020) 77:179–84. doi: 10.1136/oemed-2019-105916 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Tähkämö L, Partonen T, Pesonen A-K. Systematic review of light exposure impact on human circadian rhythm. Chronobiol Int. (2019) 36:151–70. doi: 10.1080/07420528.2018.1527773 [DOI] [PubMed] [Google Scholar]
- 50.Ho Mien I, Chua EC-P, Lau P, Tan L-C, Lee IT-G, Yeo S-C, et al. Effects of exposure to intermittent versus continuous red light on human circadian rhythms, melatonin suppression, and pupillary constriction. PLoS One. (2014) 9:e96532. doi: 10.1371/journal.pone.0096532, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Vandekerckhove M, Weiss R, Schotte C, Exadaktylos V, Haex B, Verbraecken J, et al. The role of presleep negative emotion in sleep physiology. Psychophysiology. (2011) 48:1738–44. doi: 10.1111/j.1469-8986.2011.01281.x, PMID: [DOI] [PubMed] [Google Scholar]
- 52.Vogel G, Neill D, Hagler M, Kors D. A new animal model of endogenous depression: a summary of present findings. Neurosci Biobehav Rev. (1990) 14:85–91. doi: 10.1016/S0149-7634(05)80164-2, PMID: [DOI] [PubMed] [Google Scholar]
- 53.Vandekerckhove M, Cluydts R. The emotional brain and sleep: an intimate relationship. Sleep Med Rev. (2010) 14:219–26. doi: 10.1016/j.smrv.2010.01.002, PMID: [DOI] [PubMed] [Google Scholar]
- 54.Vandekerckhove M, Wang Y-L. Emotion, emotion regulation and sleep: an intimate relationship. AIMS Neurosci. (2018) 5:1–22. doi: 10.3934/Neuroscience.2018.5.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Talbot LS, Hairston IS, Eidelman P, Gruber J, Harvey AG. The effect of mood on sleep onset latency and REM sleep in interepisode bipolar disorder. J Abnorm Psychol. (2009) 118:448–58. doi: 10.1037/a0016605, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Riemann D, Berger M, Voderholzer U. Sleep and depression—results from psychobiological studies: an overview. Biol Psychol. (2001) 57:67. doi: 10.1016/S0301-0511(01)00090-4 [DOI] [PubMed] [Google Scholar]
- 57.Palmer CA, Alfano CA. Sleep and emotion regulation: an organizing, integrative review. Sleep Med Rev. (2017) 31:6–16. doi: 10.1016/j.smrv.2015.12.006, PMID: [DOI] [PubMed] [Google Scholar]
- 58.Orchard F, Gregory AM, Gradisar M, Reynolds S. Self-reported sleep patterns and quality amongst adolescents: cross-sectional and prospective associations with anxiety and depression. J Child Psychol Psychiatry. (2020) 61:1126–37. doi: 10.1111/jcpp.13288, PMID: [DOI] [PubMed] [Google Scholar]
- 59.Jun Chen YH. A study of the subjective and objective sleep characteristics of patients with primary insomnia. Psychol Explor. (2011) 4:382–4. doi: 10.3969/j.issn.1003-5184.2011.04.018 [DOI] [Google Scholar]
- 60.Santos PD, Targa ADS, Noseda ACD, Rodrigues LS, Fagotti J, Lima MMS. Cholinergic oculomotor nucleus activity is induced by REM sleep deprivation negatively impacting on cognition. Mol Neurobiol. (2017) 54:5721–9. doi: 10.1007/s12035-016-0112-z, PMID: [DOI] [PubMed] [Google Scholar]
- 61.Galbiati A, Sforza M, Fasiello E, Casoni F, Marrella N, Leitner C, et al. The association between emotional dysregulation and REM sleep features in insomnia disorder. Brain Cogn. (2020) 146:105642. doi: 10.1016/j.bandc.2020.105642, PMID: [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.